Pharmafile Logo
Pharmafocus logo
Advanced Search

study

Showing 8 posts of 8 posts found.

Survey reveals over 2 million people impacted by long COVID in UK

June 24, 2021
COVID-19, UK, government, long covid, study

A recent survey from Imperial College London has revealed that over 2 million people in the UK may have suffered …

News
nice_new_london_office_internal_2_8

NICE guidelines on antidepressant withdrawal symptoms are misleading, study shows

October 9, 2018
Manufacturing and Production NICE, UK, addiction, antidepressants, research, study

Current NICE guidance concerning the severity of the effects of antidepressant withdrawal is misleading doctors according to research published in …

News
medicinal_cannabis_uk_review

CBD dampens activity in brain regions associated with psychosis, study shows

August 30, 2018
Research and Development CBD, King's College London, Kings College London, Marijuana, psychosis, study

Cannabidiol (CBD), one of the major constituents of cannabis, may be beneficial for patients with psychotic disorders due to its …

News
eisa0008_web

Eisai’s weight loss drug lorcaserin found safe in major study

August 28, 2018
Manufacturing and Production, Research and Development, Sales and Marketing Eisai, lorcaserin, safety, study, weight loss

Eisai’s weight loss drug lorcaserin does not increase people’s risk of major cardiovascular events according to a study of 12,000 …

News
social_media_phone_iphone_twitter_hand-38920

Russian trolls spread vaccine misinformation on Twitter

August 28, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing Russia, misinformation, public health, study, vaccines

Twitter bots and Russian trolls post content about vaccination at significantly higher rates than normal users, a new study has …

News

Letters to doctors reduce opioid prescriptions, study shows

August 10, 2018
Medical Communications OxyContin, USA, fentanyl, opioid, opioid crisis, research, study

A study has shown that Doctors who received a letter from the medical examiner’s office informing them of their patient’s …

News
mr058666-web

Merck says its Erbitux in combination with Folfox improves outcomes in colorectal cancer

July 4, 2016
Research and Development, Sales and Marketing Cancer, China, ESMO, Merck, colorectal cancer, drug trial, research, study

Merck said late-stage trials for its Erbitux (cetuximab) in combination with Folfox significantly improved progression free survival in metastatic colorectal …

News
Merck image

Merck warned over missing Januvia safety study

March 13, 2012
Research and Development FDA, Januvia, Merck, study

Merck has been warned by the FDA that it must carry out a post-marketing safety study on diabetes treatments Januvia …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024